129 Views | 70 Downloads
Correspondence: Scott R. Lambert, MD, Department of Ophthalmology, Stanford University School of Medicine, 2452 Watson Ct, Palo Alto, CA 94303 lambert7@stanford.edu, 650-725-5743
Disclosures: Scott R Lambert: Consultant, Cystic Fibrosis Foundation Therapeutics and Kala Pharmaceuticals; the following authors have no financial disclosures: Lindreth DuBois, George Cotsonis, E. Eugenie Hartmann, Carolyn Drews-Botsch. All authors meet the current ICMJE criteria for authorship.
Supported by National Institutes of Health Grants U10 EY13272, U10 EY013287, UG1 EY013272, 1UG1 EY025553, P30 EY026877 and Research to Prevent Blindness, Inc, New York, New York.
© 2019 Elsevier Inc. All rights reserved.